These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 1026339

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chemotherapy of leukemia in mice, rats, and humans relating time of humoral stimulation, tumor growth, and clinical response.
    Burke PJ, Karp JE, Vaughan WP.
    J Natl Cancer Inst; 1981 Sep; 67(3):529-38. PubMed ID: 6944525
    [Abstract] [Full Text] [Related]

  • 4. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
    Moran RE, Straus MJ.
    Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059
    [Abstract] [Full Text] [Related]

  • 5. Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria.
    Curtis JE, Cowan DH, Bergsagel DE, Hasselback R, McCulloch EA.
    Can Med Assoc J; 1975 Aug 23; 113(4):289-94. PubMed ID: 1056807
    [Abstract] [Full Text] [Related]

  • 6. Synchronization and recruitment in acute leukemia.
    Lampkin BC, Nagao T, Mauer AM.
    J Clin Invest; 1971 Oct 23; 50(10):2204-14. PubMed ID: 5286686
    [Abstract] [Full Text] [Related]

  • 7. Effect of cytostatic drugs on the kinetics of leukemic blast cells in man.
    Killmann SA.
    Schweiz Med Wochenschr; 1974 Feb 23; 104(8):278-84. PubMed ID: 4814680
    [No Abstract] [Full Text] [Related]

  • 8. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I, Hara M, Ohmoto E, Oda Y, Endo Y, Fujimoto S, Uchida K, Takaoka K, Watanabe S, Lai M, Kohi F, Kitajima K, Kimura I, Sanada H, Tokioka M, Adachi T, Yorimitsu S.
    Gan To Kagaku Ryoho; 1982 Sep 23; 9(9):1617-22. PubMed ID: 6964050
    [Abstract] [Full Text] [Related]

  • 9. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
    Blumenreich MS, Chou TC, Andreeff M, Vale K, Clarkson BD, Young CW.
    Cancer Res; 1984 Feb 23; 44(2):825-30. PubMed ID: 6692380
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
    Winton EF, Hearn EB, Martelo O, Presant CA, Adler S, Vogler WR, Raney M, Logan T, Silberman HM, Omura GA.
    Cancer Treat Rep; 1985 Feb 23; 69(7-8):807-11. PubMed ID: 2410119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.